onalcoholic fatty liver treatment
Phase 3
- Conditions
- ASH.Nonalcoholic steatohepatitis (NASH)K75.81
- Registration Number
- IRCT20161210031316N2
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
Non-alcoholic steatohepatitis and liver enzymes are based on indicators of liver function and ultrasound
Age over 18 years
Exclusion Criteria
alcohol
intake of angiotensin receptor antagonists
use of angiotensin converting enzyme inhibitors
resistance-resistant hypertension
Uncontrolled Diabetes
hypotension
serious interactions with other patient medications
other causes of liver steatosis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method